1M6MYTD1Å5ÅMAKS.
Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 56,05 € (+1.515,27 %). Medianen er 35,78 € (+931,12 %).
| Køb |
5 |
| Behold |
13 |
| Sælg |
2 |
Nyheder Til nyhedsfeedet
Tilray Brands to buy HelloMD and build vertically integrated medical cannabis platform in Canada
Tilray Brands announced on June 29 that it will acquire HelloMD's Canadian medical cannabis assets after winning a court-approved sale process. The deal pairs HelloMD's digital telehealth and patient engagement platform with Tilray's cultivation, clinical expertise and national fulfillment to create a connected pathway for patients and practitioners. Tilray highlighted opportunities to expand into adjacent wellness categories like sleep and pain support; financial terms were not disclosed. Shares of Tilray are down more than 50% year-to-date. » Mere på finance.yahoo.com
Virksomhedstal
| (EUR) | maj 2026 | |
|---|---|---|
| Omsætning | 241,83 mio. | 10,93 % |
| Bruttofortjeneste | 72,39 mio. | 11,49 % |
| Nettoresultat | -42,55 mio. | 97,24 % |
| EBITDA | 12,75 mio. | 100,78 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 414,11 mio. € |
Antal aktier | 111,83 mio. |
Højeste/laveste i 52 uger | 20,00 € - 3,16 € |
| Udbytte | Nej |
Beta | 1,92 |
P/E (PE Ratio) | -3,22 |
PEG (PEG Ratio) | -0,02 |
K/I (PB Ratio) | 0,30 |
P/S (PS Ratio) | 0,42 |
Virksomhedsprofil
| Navn | TILRAY BRANDS NEW O.N. |
| CEO | Irwin David Simon |
| Hjemsted | Leamington,
on USA |
| Websted | |
| Sektor | Sundhed |
| Branche | Bioteknologi |
| Medarbejdere | 3.595 |
